ECM
DRNA

Endurant Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Endurant Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-13,768
Closed -$303K – 72
2019
Q4 		$303K Buy
+13,768
New +$303K 0.1% 49
2018
Q1 		– Sell
-18,837
Closed -$170K – 88
2017
Q4 		$170K Buy
+18,837
New +$170K 0.05% 75